Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
8/8/2025
Wuxi Apptec Strengthens European Foothold with Luxembourg Expansion Am...
8/8/2025
ExoNeuglia Raises Series A+ Funding to Advance iPSC Ther...
8/8/2025
Fujian Haixi Pharma Files for Hong Kong IPO
8/8/2025
Hengrui Launches Phase 3 Trial of Trastuzumab Rezetecan Combo for AGC
8/8/2025
Boan's Dulaglutide Biosimilar Secures NMPA Approval in China
8/8/2025
Triple Squeeze Threatens China's Global Drug Push
8/8/2025
Shanghai Unveils 18 New Measures to Boost Commercial Health Insurance ...
8/8/2025
Minghui Raises $131M to Accelerate Clinical and Commercial Expansion
8/8/2025
Innogen Launches $87M Hong Kong IPO to Fund Trials and Launches
8/8/2025
AlphaGen Closes Series A Funding
8/8/2025
Dizal's Birelentinib Granted FDA Fast Track for Treatment-Resistant CL...
8/8/2025
AsiFlyer Secures New Funding to Propel Next‑Gen Botulinum Toxin
8/8/2025
AstraZeneca Expands Use of Fasenra in China
8/8/2025
Bio-Thera Launches Ambitious Triple-Immunotherapy Trial for Advanced S...
8/8/2025
Minghui's MHB042C Earns Green Light for Clinical Trials in Advanced So...
8/6/2025
China Urges Price Discipline as Drugmakers Flood Latest VBP Tender
8/6/2025
XTalPi Signs US$6 Billion Global Drug Discovery Deal with DoveTree
8/6/2025
Everest's Nefecon Won NMPA Approval for Poduction Expansion to Meet Ri...
8/6/2025
Global Pharma Bets on China's AI Biotech for Next-Gen Drug Discovery
8/6/2025
CDE Releases Updated Roster of External Drug Review Experts
8/6/2025
China Launches 11th National VBP Round with New Flexibility for Hospit...
8/6/2025
China's CGT Boom: NMPA's CDE and Tsinghua Team Publish Eight-Year Revi...
8/6/2025
MediLink and Akeso Launch First ADC–Ivonescimab Combo Trial
8/6/2025
Chinese Private Biopharma Sees Surge in July Financing, Highest Since ...
8/6/2025
Fosun's Exit from Gland Pharma Stalls as Share Price Surge Complicates...
8/6/2025
CDE Solicits Comments on Guidelines for Developing Appropriate Drug Pa...
8/6/2025
CDE Seeks Public Comments on Revised Technical Guidelines for Recombin...
8/5/2025
Zenitar Raises ~CNY 400M to Accelerate AI-Driven Drug Discovery and O...
8/5/2025
EMBIOS Secures Pre-A Funding to Advance First-in-Class Autoimmune Ther...
8/5/2025
CSPC's Chemically Synthesized Semaglutide Injection Accepted for Revie...
Page:
2
/
56
Total number of articles:
1678
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit